Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
5.93
+0.02 (0.34%)
At close: Oct 30, 2025, 4:00 PM EDT
5.89
-0.04 (-0.67%)
After-hours: Oct 30, 2025, 4:01 PM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $821.69 million as of October 30, 2025. Its market cap has decreased by -21.60% in one year.
Market Cap
821.69M
Enterprise Value
326.93M
1-Year Change
-21.60%
Ranking
Category
Stock Price
$5.93
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $821.69M, a decrease of -46.43%. That is a compound annual growth rate of -9.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 821.00M | -18.78% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | 3.41B | 147.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |